{"id":162498,"date":"2022-06-09T01:55:07","date_gmt":"2022-06-09T05:55:07","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/santhera-and-reveragen-to-present-new-data-with-vamorolone-at-2022-parent-project-muscular-dystrophy-conference\/"},"modified":"2024-08-18T11:44:51","modified_gmt":"2024-08-18T15:44:51","slug":"santhera-and-reveragen-to-present-new-data-with-vamorolone-at-2022-parent-project-muscular-dystrophy-conference","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/santhera-and-reveragen-to-present-new-data-with-vamorolone-at-2022-parent-project-muscular-dystrophy-conference.php","title":{"rendered":"Santhera and ReveraGen to Present New Data with Vamorolone at 2022 Parent Project Muscular Dystrophy Conference"},"content":{"rendered":"<p><![CDATA[Pratteln, Switzerland, and Rockville, MD, USA, June\u00a09, 2022 \u2013 Santhera Pharmaceuticals (SIX: SANN) and ReveraGen BioPharma, Inc announce presentations of new data with vamorolone in Duchenne muscular dystrophy (DMD).]]><\/p>\n<p>Continue reading here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/06\/09\/2459298\/0\/en\/Santhera-and-ReveraGen-to-Present-New-Data-with-Vamorolone-at-2022-Parent-Project-Muscular-Dystrophy-Conference.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Santhera and ReveraGen to Present New Data with Vamorolone at 2022 Parent Project Muscular Dystrophy Conference\">Santhera and ReveraGen to Present New Data with Vamorolone at 2022 Parent Project Muscular Dystrophy Conference<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Continue reading here: Santhera and ReveraGen to Present New Data with Vamorolone at 2022 Parent Project Muscular Dystrophy Conference <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/santhera-and-reveragen-to-present-new-data-with-vamorolone-at-2022-parent-project-muscular-dystrophy-conference.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-162498","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/162498"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=162498"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/162498\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=162498"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=162498"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=162498"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}